209 results on '"Bronze-da-Rocha, Elsa"'
Search Results
2. #1613 Gadolinium and gadoteric acid's short-term impact on kidney function and lipid profile
3. #1358 The association between TNFRSF1B rs1061624 polymorphism and hypertension in end-stage kidney disease patients on dialysis
4. Age-Related Changes in Clinical and Analytical Variables in Chronic Hemodialyzed Patients
5. Toxicity Mechanisms of Gadolinium and Gadolinium-Based Contrast Agents-A Review
6. Age-Related Changes in Clinical and Analytical Variables in Chronic Hemodialyzed Patients
7. Impact of TNFRSF1B (rs3397, rs1061624 and rs1061622) and IL6 (rs1800796, rs1800797 and rs1554606) Gene Polymorphisms on Inflammatory Response in Patients with End-Stage Kidney Disease Undergoing Dialysis.
8. Interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysis
9. #4713 TUMOR NECROSIS FACTOR RECEPTOR 2 POLYMORPHISM (RS1061622) AND INFLAMMATORY RESPONSE IN END-STAGE RENAL DISEASE PATIENTS UNDER DIALYSIS
10. The Association of Leptin with Left Ventricular Hypertrophy in End-Stage Kidney Disease Patients on Dialysis
11. The Association of Leptin with Left Ventricular Hypertrophy in End-Stage Kidney Disease Patients on Dialysis
12. DNA Damage in End-Stage Renal Disease Patients. Assessment by In Vitro Comet Assay and by Cell-Free DNA Quantification
13. New Insights into Adiponectin and Leptin Roles in Chronic Kidney Disease
14. New Insights into Adiponectin and Leptin Roles in Chronic Kidney Disease
15. Impact of UGT1A1 gene variants on total bilirubin levels in Gilbert syndrome patients and in healthy subjects
16. Bilirubin Dependence on UGT1A1 Polymorphisms, Hemoglobin, Fasting Time and Body Mass Index
17. Novel ancestral Dysferlin splicing mutation which migrated from the Iberian peninsula to South America
18. Performance of In Silico Tools for the Evaluation of UGT1A1 Missense Variants
19. Evaluation of the Reactivity of Sera from Patients with Systemic Lupus Erythematosus Against the Human MCP1
20. Subpopulations of High-Density Lipoprotein: Friends or Foes in Cardiovascular Disease Risk in Chronic Kidney Disease?
21. MO810INTERLEUKIN-6 (-174G/C) POLYMORPHISM, RS1800795, IN ESRD PATIENTS' OUTCOME*
22. MO472A PRELIMINARY STUDY OF POTENTIAL BIOMARKERS FOR EARLY DIAGNOSIS IN CHRONIC KIDNEY DISEASE
23. MO735INTERPLAY BETWEEN GDF-15 AND LEFT VENTRICULAR HYPERTROPHY IN END-STAGE RENAL DISEASE PATIENTS ON DIALYSIS
24. Interleukin 6 (rs1800795) and Pentraxin 3 (rs2305619) Polymorphisms - Association with Inflammation and All-Cause Mortality in End-stage-renal Disease Patients on Dialysis
25. Bilirubin Levels and Redox Status in a Young Healthy Population
26. The human autoantigen MCP1 is required during early stages of DNA replication
27. Cell-free DNA as a marker for the outcome of end-stage renal disease patients on haemodialysis
28. P1531DIURETIC USE IN HEMODIALYSIS PATIENTS: BENEFIC ASSOCIATION WITH RESIDUAL RENAL FUNCTION AND ALL-CAUSE MORTALITY
29. P1570INTERLEUKIN-6 (RS1800795) AND PENTRAXIN 3 (RS2305619) GENETIC POLYMORPHISMS AND THEIR RELATION WITH INFLAMMATION AND ALL-CAUSE MORTALITY IN ESRD PATIENTS ON DIALYSIS
30. P1263ASSOCIATION OF LEFT VENTRICULAR HYPERTROPHY AND ADIPOCYTOKINES IN PATIENTS ON DIALYSIS
31. P1581IMPACT OF ACHIEVING LDL CHOLESTEROL LOWER THAN 100 MG/DL WITH STATINS, ON LIPID PROFILE AND INFLAMMATION IN END-STAGE RENAL DISEASE PATIENTS
32. P0739PANEL OF SENSITIVE BIOMARKERS OF THE PRIMARY RESPONSE TO RENAL INJURY FOR AN EARLY DIAGNOSIS OF CHRONIC KIDNEY DISEASE
33. Molecular cloning of metaphase chromosome protein 1 (MCP1), a novel human autoantigen that associates with condensed chromosomes during mitosis
34. Effects of statins therapy on LDL subfractions and inflammation in end-stage renal disease patients on dialysis
35. Impact of a School-Based Intervention Protocol--ACORDA Project--On Adipokines in an Overweight and Obese Pediatric Population.
36. Artelastin is a cytotoxic prenylated flavone that disturbs microtubules and interferes with DNA replication in MCF-7 human breast cancer cells
37. Long Pentraxin 3 as a Broader Biomarker for Multiple Risk Factors in End-Stage Renal Disease: Association with All-Cause Mortality
38. SP666MACHINE LEARNING IN PREDICTION OF VULNERABLE OR RESILIENT END-STAGE RENAL DISEASE PATIENTS
39. SP543ASSOCIATION OF PTX3, NT-proBNP AND LEFT VENTRICULAR HYPERTROPHY IN PATIENTS ON DIALYSIS
40. FP725PENTRAXIN 3 IN END-STAGE RENAL DISEASE: MULTIPLE RISK BIOMARKER AND PREDICTOR OF ALL-CAUSE MORTALITY
41. FP730EFFECTS OF STATINS THERAPY ON LDL SUBFRACTIONS AND INFLAMMATION, IN END-STAGE RENAL DISEASE PATIENTS ON DIALYSIS
42. SP674IN DIALYSIS PATIENTS FUROSEMIDE THERAPY IS FAVORABLY RELATED WITH INFLAMMATORY RESPONSE, FIBRINOLYSIS, AND BIOMARKERS OF RESIDUAL RENAL FUNCTION
43. SP637INFLAMMATION AND CELL-FREE DNA AS BIOMARKERS FOR THE OUTCOME OF END STAGE RENAL DISEASE PATIENTS
44. The Protective Role of Adiponectin for Lipoproteins in End-Stage Renal Disease Patients: Relationship with Diabetes and Body Mass Index
45. Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patients
46. Cell-free DNA as a marker for the outcome of end-stage renal disease patients on haemodialysis.
47. SP348ASSOCIATION OF NT-PRO-BNP WITH ANEMIA, INFLAMMATION AND KIDNEY FUNCTION IN PORTUGUESE DIALYSIS PATIENTS
48. SP665PENTRAXIN 3 VERSUS GROWTH DIFFERENTIATION FACTOR-15: ASSOCIATION WITH INFLAMMATION, IRON HOMEOSTASIS AND ERYTHROPOIESIS IN END-STAGE RENAL DISEASE PATIENTS
49. SP276DNA DAMAGE IN END STAGE RENAL DISEASE PATIENTS: COMET ASSAY AND CELL FREE DNA
50. SP658INFLAMMATORY RESPONSE, FIBRINOLYSIS, AND BIOMARKERS OF RESIDUAL KIDNEY FUNCTION IN HEMODIALYSIS PATIENTS: RELATIONSHIP WITH FUROSEMIDE THERAPY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.